Congratulations to the team at The University of Tennessee Medical Center on being the first in the U.S. to implement the A-View® Endotracheal Balloon Catheter in a cardiothoracic surgery.


(from left to right) Nick Harper, RCIS, Sr. Acute Care Product Manager for DeRoyal Industries, Inc., George Brandon, M.D., Ph.D, A-View® device co-inventor, Tommy Christianson, M.D., Arno Nierich, M.D., Ph.D, A-View®balloon inventor & Blake Moore, M.D.

A-View® Endotracheal Balloon Catheter


The A-View® balloon provides complete visualization of the distal ascending aorta during TEE, thus eliminating the 'blind spot'. This is accomplished by filling the air-void within the trachea with a saline-filled balloon, allowing for a complete diagnosis of dangerous plaques at risk for potential dislodgement prior to CPB cannulation and aortic cross clamping. The A-View® balloon has been proven to reduce the risk of periprocedural stroke by 30%*.

* Study can be found on A-View page.


UT-CenteredLogo-RGB-orange_1A very special thanks to Blake Moore, M.D. and Tommy Christianson, M.D. on their willingness to adopt the A-View® balloon into their daily practice, ensuring better patient outcomes during cardiac-related surgeries.